Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback